Volume 94 Issue 30 | p. 17 | Concentrates
Issue Date: July 25, 2016

Galenica to acquire Relypsa

Department: Business
Keywords: polymers, hyperkalaemia, acquisition

Galenica, a midsized Swiss drugmaker, has agreed to acquire the California biotech firm Relypsa for $1.5 billion in cash. Founded in 2007, Relypsa develops polymeric medicines for patients with conditions that can be treated in the gastrointestinal tract. FDA approved its first product, a treatment for elevated blood potassium levels, in October 2015. The drug, Veltassa, is based on a fluorinated polymer manufactured by the fine chemicals companies Saltigo and Patheon.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment